Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Hemophilia A

Recent news which mentions Hemophilia A

Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
Tickers BIOVF SNY
Tags Market News SNY News
From Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
Tickers BMRN
Tags General Market News News
From Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
Tickers SNY
Tags General Briefs Phase 3 Trial
From Benzinga
Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program
Tickers GBIO
Tags Briefs Biotech Movers
From Benzinga
Sigilon Therapeutics Issues An Update On Its Early-Stage Hemophilia Study
Tickers SGTX
Tags News Penny Stocks Health Care
From Benzinga
Centessa Stock Surges On Positive Data From Hemophilia Candidate
Tickers CNTA
Tags Trading Ideas CNTA Health Care
From Benzinga
BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy
Tickers BMRN
Tags Biotech Benzinga Briefs
From Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Achieve Stable, Durable FVIII Expression
Tickers RHHBF RHHBY RHHVF
Tags Briefs Biotech Benzinga
From Benzinga
Roche Unveils New Hemlibra Data Reinforcing Safety Profile In Hemophilia A
Tickers RHHBF RHHBY RHHVF
Tags RHHBY Market News News
From Benzinga
BioMarin Expects EMA's CHMP Opinion In 1H 2022 For Its Hemophilia A Gene Therapy, FDA Resubmission In 2Q'22
Tickers BMRN
Tags gene therapy Benzinga Health Care
From Benzinga
Serious Adverse Event Triggers FDA Clinical Hold On Sigilon Therapeutics' Hemophilia A Trial, Shares Drop
Tickers SGTX
Tags News Briefs Hemophilia A
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.